Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
1.
Emerg Infect Dis ; 26(2): 327-331, 2020 02.
Article in English | MEDLINE | ID: mdl-31961312

ABSTRACT

Incidence of human granulocytic anaplasmosis is rising in Maine, USA. This increase may be explained in part by adoption of tick panels as a frequent diagnostic test in persons with febrile illness and in part by range expansion of Ixodes scapularis ticks and zoonotic amplification of Anaplasma phagocytophilum.


Subject(s)
Anaplasma phagocytophilum/isolation & purification , Anaplasmosis/epidemiology , Ixodes/microbiology , Adolescent , Adult , Aged , Anaplasmosis/etiology , Animals , Child , Female , Humans , Maine/epidemiology , Male , Middle Aged , Young Adult
2.
Aquat Toxicol ; 124-125: 188-96, 2012 Nov 15.
Article in English | MEDLINE | ID: mdl-22975441

ABSTRACT

The canonical Wnt/ß-catenin signaling pathway is critical during early teleost development for establishing the dorsal-ventral axis. Within this pathway, GSK-3ß, a key regulatory kinase in the Wnt pathway, regulates ß-catenin degradation and thus the ability of ß-catenin to enter nuclei, where it can activate expression of genes that have been linked to the specification of the dorsal-ventral axis. In this study, we describe the morphological abnormalities that resulted in zebrafish embryos when axis determination was disrupted by environmental contaminants. These abnormalities were linked to abnormal nuclear accumulation of ß-catenin. Furthermore, we demonstrated that the developmental abnormalities and altered nuclear ß-catenin accumulation occurred when embryos were exposed to commercial GSK-3ß inhibitors. Zebrafish embryos were exposed to commercially available GSK-3 inhibitors (GSK-3 Inhibitor IX and 1-azakenpaullone), or common environmental contaminants (dibutyl phthalate or the polycyclic aromatic hydrocarbons phenanthrene and fluorene) from the 2 to 8-cell stage through the mid-blastula transition (MBT). These embryos displayed morphological abnormalities at 12.5 h post-fertilization (hpf) that were comparable to embryos exposed to lithium chloride (LiCl) (300 mM LiCl for 10 min, prior to the MBT), a classic disruptor of embryonic axis determination. Whole-mount immunolabeling and laser scanning confocal microscopy were used to localize ß-catenin. The commercial GSK-3 Inhibitors as well as LiCl, dibutyl phthalate, fluorene and phenanthrene all induced an increase in the levels of nuclear ß-catenin throughout the embryo, indicating that the morphological abnormalities were a result of disruption of Wnt/ß-catenin signaling during dorsal-ventral axis specification. The ability of environmental chemicals to directly or indirectly target GSK-3ß was assessed. Using Western blot analysis, the ability of these chemicals to affect enzymatic inhibitory phosphorylation at serine 9 on GSK-3ß was examined, but no change in the serine phosphorylation state of GSK-3ß was detected in exposed embryos. Furthermore, polycyclic aromatic hydrocarbons and dibutyl phthalate had no direct effect on the in vitro kinase activity of GSK-3ß. While developmental abnormalities resulting from these axis-disrupting contaminants were linked to ß-catenin accumulation in nuclei, the details of the disruption of this signaling pathway remain unknown. Since phenanthrene and fluorene as well as other hydrocarbons have been shown to disrupt axial development in sea urchin embryos, and since axis determination and the Wnt/ß-catenin signaling pathway are highly conserved, we propose that these environmental contaminants may impact embryo development through a similar mechanism across phyla.


Subject(s)
Body Patterning/drug effects , Polycyclic Aromatic Hydrocarbons/toxicity , Water Pollutants, Chemical/toxicity , Wnt Proteins/metabolism , Wnt Signaling Pathway/drug effects , Zebrafish/embryology , Animals , Cell Nucleus/drug effects , Cell Nucleus/metabolism , Embryo, Nonmammalian/drug effects , Enzyme Activation/drug effects , Glycogen Synthase Kinase 3/metabolism , Glycogen Synthase Kinase 3 beta , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL